The global oncology pharmaceutical market features a dominant group of top-tier multinational corporations that lead the research, development, and commercialization of breakthrough cancer treatments. This group includes industry giants such as Roche, Novartis, Merck, Pfizer, Johnson & Johnson, Bristol Myers Squibb, AstraZeneca, Sanofi, GlaxoSmithKline, Takeda, AbbVie, Eli Lilly, Amgen, Bayer, Gilead Sciences, Astellas, Merck KGaA, BeiGene, Regeneron, and Daiichi Sankyo, all driving innovation across chemotherapy, immunotherapy, and targeted treatments.